Skip to main content

Diabetes Mellitus: Clinical Presentation and Diagnosis!

 CLINICAL PRESENTATION AND DIAGNOSIS OF DM


2. SCREENING

  • American Diabetes Association (ADA) recommends routine screening for T2 DM every 3 years in all adults starting at 45 years of age.
  • Testing of T2 DM should be considered in any adult, regardless of their age, who have a BMI greater than or equal to 25kg/m2.
  • The ADA does not currently recommend widespread screening for T1 DM because of the relatively low incidence in the general population, although measurement of Islet antibodies may be appropriate for high-risk individuals.


3.GESTATIONAL DIABETES:

"Gestational diabetes is the glucose intolerance in women during pregnancy".

  • All pregnant women who have risk factors for T2 DM should be screened for undiagnosed T2 DM at their first prenatal visit using standard diagnostic criteria. 
  • Any women found to have diabetes in the early point at pregnancy is considered to have T2 DM or GDM.
  • All other pregnant women, not currently known to have DM should be screened for GDM with a 75g oral-glucose tolerance test (OGTT) between weeks 24 and 28 of gestation. 


4.ADA CRITERIA FOR THE DIAGNOSIS OF DM:

1. Symptoms of diabetes plus a casual plasma glucose conc. greater than or equal to 200mg/dL.
    "Casual is defined as any time of day without regard to time since last meal, the classic symptoms of        Diabetes include polyuria, polydipsia, and unexplained weight loss.

2. FPG greater or equal to 126mg/dL. "Fasting is defined as no caloric intake for at least 8 hours".

3. 2 hr. post load glucose greater or equal to 200mg/dL during OGTT. The test should be performed as     described by WHO using a glucose load containing the equivalent of 75g of anhydrous glucose               dissolved in water.

4. A1c greater or equal to 6.5%. The test should be performed in a laboratory using a method that is            NGSP Certified to DCCT Assay.


Labels:

Comments

Post a Comment

Popular posts from this blog

Hospital Acquired Pneumonia- Definition, Predisposing Factors, Clinical Features and Management!

 HOSPITAL ACQUIRED PNEUMONIA Definition: "HAP refers to a new episode of pneumonia occurring at least 2 days after the administration to hospital. It is the most common Hospital Acquired Infection (HAI) and leading cause of HAI-associated death". Predisposing factors: Aspiration of nasopharyngeal secretion Bacteria introduced into the lower GIT. Bacteriaemia Old age Mode of Spread:  Droplet infection Infecting agent: Bacteria: S.pneumonia , S.aureus , H.influenza Virus: Adenovirus, Corona virus, Herpes Simplex Clinical Features: Purulent sputum New radiological infiltrates Temperature > 38 degree Celsius Leukocytosis Investigations: Chest Pain:  to confirm the diagnosis and exclude complication. Pulse Oximetry : to monitor response to oxygen therapy, if SaO2 < 93% features of sever pneumonia, identify ventilatory failure or acidosis. Cell count:  ESR, Neutrophil leukocytosis Microbiological studies:  for severe CAP and those that do not respond to ...
Post a Comment
Read more

Management of H.pylori and NSAID-associated ulcers Eradication!

MANAGEMENT FOR H.PYLORI ERADICATION It is known that H.pylori infection is associated with over 90% of duodenal ulcers and 80% of Gastric Ulcers. Antibiotics alone or acid-suppressing agents alone, do not eradicate H.pylori . Both therapies act synergistically as growth of the organism occurs at elevated pH and antibiotics efficacy is enhanced during growth. Additionally, increasing intragastric pH may enhance antibiotic absorption. High eradication rates are achieved by a short course of Triple Therapy consisting of:            1 .PPI                                         2. Clarithromycin                         3. Amoxicillin/Metronidazole          in a twice recommended simultaneous regimen. First-Line Therapy :  European Guidelines recommended 1 we...
Post a Comment
Read more